Arkolith/Insider Trading/RNAC/Form 4

Barabe Timothy C

DirectorCartesian Therapeutics, Inc. (RNAC) · full profile →Form 4 · filed Dec 8, 2025
Net Buying
Open-Market Buys
$206K
Open-Market Sells
$0
Net Open-Market Flow
$206K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Buy(P)30K$6.86$206K54K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-25-000132) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML